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Abstract
 Purpose—Gallbladder diseases and cholecystectomy may play a role in the development of 
colorectal cancer (CRC). Our aim was to investigate the association between cholecystectomy and 
CRC risk overall and by sex, family history, anatomical location, and tumor mismatch repair 
(MMR) status.
 Methods—This study comprised 5,847 incident CRC cases recruited from population cancer 
registries in Australia, Canada and USA into the Colon Cancer Family Registry between 1997 and 
2012, and 4,970 controls with no personal history of CRC who were either randomly selected 
from the general population or were spouses of the cases. The association between 
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cholecystectomy and CRC was estimated using logistic regression, after adjusting for confounding 
factors.
 Results—Overall, there was no evidence for an association between cholecystectomy and 
CRC (odds ratio [OR] = 0.88, 95% confidence interval: 0.73, 1.08). In the stratified analyses, there 
was no evidence for a difference in the association between women and men (P=.54), between 
individuals with and without family history of CRC in first-degree relative (P=.64), between tumor 
anatomical locations (P=.45), or between MMR-proficient and MMR-deficient cases (P=.54).
 Conclusion—Cholecystectomy is not a substantial risk factor for CRC, regardless of sex, 
family history, anatomical location, or tumor MMR status.
Keywords
gallbladder; cholecystectomy; mismatch repair; colorectal cancer
 Introduction
Colorectal cancer (CRC) accounts for 10% of all cancer incidence and is the fourth ranking 
cause of cancer mortality worldwide [1]. In 2012, 746,000 men and 614,000 women were 
diagnosed with CRC globally, with highly industrialized and urbanized societies (including 
North America, most European countries, Japan and Australia) contributing to more than 
half. Identifying risk factors associated with CRC may inform strategies to prevent and 
detect cancers at an early stage. Certain medical conditions and interventions may play a 
role in the development of CRC [2].
Gallbladder diseases such as gallstones which lead to gallbladder inflammation 
(cholecystitis) are highly prevalent in Western populations [3,4]. The lifetime risk of 
developing gallstones in Western populations is between 5% and 25% and women in the US 
under 40 years of age are at nearly twice the risk of developing gallstones than men[5]. The 
common treatment for inflammatory gallstones, cholecystectomy, has the potential to lead to 
increased bile exposure in the colon and rectum. Bile acids cause DNA damage probably 
indirectly through the induction of oxidative stress and the production of reactive oxygen 
species. Excessive DNA damage may cause genetic instability and increase mutations of 
tumor suppressor genes and oncogenes, subsequently increasing the risk of CRC [6].
Previous studies have reported conflicting results on associations between gallstones and/or 
cholecystectomy and CRC [7,8] or colorectal adenoma [9]. Further, risks may be 
differentially associated with cancer at different anatomical locations within the colon [10]. 
No previous studies have examined the association between cholecystectomy and CRC 
according to their tumor mismatch repair (MMR) status. Here, we investigated associations 
between cholecystectomy and CRC risk by sex, family history, anatomical location and 
tumor MMR status.
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 Materials and Methods
 Study Sample
This study was designed as a retrospective case-control study. Cases were individuals 
diagnosed with incident colon or rectal cancer who were recruited through population cancer 
registries from four centers of the Colon Cancer Family Registry between 1997 and 2012, 
Cancer Care Ontario (Toronto, Canada), Fred Hutchinson Cancer Research Center (Seattle, 
US), Mayo Clinic (Rochester, US), and The University of Melbourne (Melbourne, Australia) 
[11]. We only included cases interviewed by staff from the Colon Cancer Family Registry 
within 5 years of diagnosis. Controls were either individuals with no personal history of 
CRC who were recruited randomly from the general population through Medicare and 
Driver’s License files, telephone subscribers lists, electoral rolls, or the CRC cases’ spouses 
with no personal history of CRC. For all participants, we excluded those without 
information on whether or not they had cholecystectomy.
 Data Collection
We collected data on demographic information, personal and familial history of CRC, 
medical history including surgeries, medical conditions and drug use, alcohol intake, 
smoking status for all participants and reproductive history for women at the time of 
baseline recruitment. Uniform questionnaires (http://coloncfr.org/questionnaires) were used 
to acquire data by telephone interviews (Fred Hutchinson Cancer Research Center, 
University of Melbourne and Mayo Clinic) and mails (Cancer Care Ontario and Mayo 
Clinic). All participants were asked whether or not they had surgical removal of their 
gallbladder and if so, at what age they were at the time of the removal.
 Tumor molecular characterization
CRCs were characterized for MMR-deficiency by microsatellite instability (MSI) using a 
ten-marker panel (four mononucleotide markers (BAT25, BAT26, BAT40, and BAT34C4), 
five dinucleotide markers (D5S346, D17S250, ACTC, D18S55, and D10S197), and one 
penta-mono-tetra compound-repeat marker (MYCL)) and/or by immunohistochemistry 
(IHC) for the four MMR proteins. Tumors were classified as MMR-deficient if they were 
MSI-high (≥30% unstable markers) and/ or showed loss of expression of one or more of the 
MMR proteins by IHC; and MMR-proficient if they were microsatellite stable (no unstable 
markers) or MSI-low (<30% unstable markers) and/or showed normal expression of all four 
MMR proteins by IHC [11].
 Statistical Analysis
Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the association 
between cholecystectomy and CRC were estimated using multivariable unconditional 
logistic regression. We estimated the associations stratified by sex, first-degree family 
history, anatomical location, and tumor MMR status. We investigated potential interactions 
between cholecystectomy status and age at study recruitment (≤45, 45-55, 55-65 and >65 
years), sex, recent body mass index (BMI) and BMI at age 20 years (underweight, normal, 
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overweight and obese) using likelihood ratio tests comparing the results with and without 
the interaction terms in the logistic regression models.
To investigate whether the time since cholecystectomy was associated with CRC risk for the 
participants that had undergone cholecystectomy, we compared the mean of time since 
cholecystectomy between cases (age at CRC diagnosis minus age at cholecystectomy) and 
controls (age at study recruitment minus age at cholecystectomy) using a multivariable 
linear regression model.
Some centers of the Colon Cancer Family Registry used stratified sampling based on family 
history for recruitment, and we did take this into account when combining and analyzing the 
data. To adjust for the stratified sampling, we gave each individual a probability weight 
equal to the reciprocal of the family sampling fraction. All statistical analyses were 
conducted using STATA version 13.0 (StataCorp, College Station, TX).
 Results
This study comprised 5,847 pathologically confirmed CRC cases, and 4,243 population-
based controls and 727 spouse-controls (Figure 1). Baseline characteristics of cases and 
controls are presented in Table 1.
In total, 521 (8.9%) cases and 555 (11.2%) controls had undergone cholecystectomy. 
Overall, there was no evidence for an association between cholecystectomy and CRC 
(OR=0.88, 95% CI: 0.73, 1.08) after adjusting for confounding factors. In stratified analyses, 
there was no evidence for a difference in the association between women and men (P=.54), 
between individuals with and without a family history of CRC in first-degree relative (P=.
64), between tumor anatomical locations (P=0.45), or between MMR-proficient and MMR-
deficient cases (P=.54) (Table 2). There was no evidence for interactions between 
cholecystectomy status and age at study recruitment, sex, recent BMI and BMI at age 20 
years (details not shown).
Moreover, there was no evidence for a difference in the time since cholecystectomy between 
cases and controls (14.5 (SD 12.1) years vs. 15 (SD 11.6) years; mean difference: −0.0003, 
95%CI: −0.004, 0.003 years, P=.86), after adjusting for confounding factors.
 Discussion
We found no evidence for an association between cholecystectomy and CRC risk, overall or 
by sex, first-degree family history of CRC, anatomical location or tumor MMR status. This 
study is the first to examine the association according to tumor MMR status.
Although a few studies have reported a positive association between cholecystectomy and 
CRC risk [12] [13], previous meta-analyses have reported that cholecystectomy was not 
associated with the risk of proximal colon cancer [7], rectal cancer [8] or colorectal adenoma 
[9]. However, most of the previous studies adjusted only for age and sex [10]. In our current 
study, we adequately adjusted for additional important confounding factors such as obesity, 
diabetes, and family history.
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The strengths of our study include large sample size and high quality data of the Colon 
Cancer Family Registry, which employs standardized protocols for data and biospecimens 
collection [11]. One limitation of our study is the possibility of recall bias because 
cholecystectomy information was self-reported and not validated by medical records. 
However, a previous study reported 99.6% agreement between self-report and medical 
records for cholecystectomy [14]. Further, given approximately 90% of our study 
participants are Caucasians from developed countries, the study results may not be 
applicable to other populations.
In conclusion, our findings suggest that cholecystectomy is not a substantial risk factor for 
CRC, regardless of sex, family history, anatomical location, or tumor MMR status.
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Figure 1. 
Selection of colorectal cancer cases and controls from the Colon Cancer Family Registry
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Table 1
Baseline characteristics of colorectal cancer cases and controls
Controls, N (%)
Variables Cases, N (%)
(n = 5847)
Total controls
(n = 4970)
Population controls
(n = 4243)
Spouse controls
(n =727)
Age at recruitment, years
 Mean (SD) 55.2 (11.8) 57.5 (11.6) 58.4 (11.7) 52.5 (10)
 Median (range) 54 59 60 52
Sex
 Female 2959 (50.6) 2630 (52.9) 2191 (51.6) 439 (60.4)
 Male 2888 (49.4) 2340 (47.1) 2052 (48.4) 288 (39.6)
Recruitment centre
 Cancer Care Ontario 2098 (35.9) 1920 (38.6) 1920 (45.2) 0
 University of Melbourne 807 (13.8) 719 (14.5) 270 (6.4) 449 (61.8)
 Mayo Clinic 623 (10.7) 278 (5.6) 0 278 (38.2)
 Fred Hutchinson Seattle 2319 (39.6) 2053 (41.3) 2053 (48.4) 0
Cholecystectomy
 Yes 521 (8.9) 555 (11.2) 504 (11.9) 51 (7)
 No 5326 (91.1) 4415 (88.8) 3739 (88.1) 676 (93)
Family history of CRC (first-degree
relative)
 Yes (at least 1 affected) 1248 (21.3) 529 (10.6) 460 (10.8) 69 (9.5)
 No 4599 (78.7) 4441 (89.4) 3783 (89.2) 658 (90.5)
Body mass index, recent (kg/m2)
 Underweight (<18.5) 86 (1.5) 57 (1.2) 50 (1.2) 7 (1)
 Normal (18.5-24.9) 2010 (34.4) 2020 (40.6) 1732 (40.8) 288 (39.6)
 Overweight (25.0-29.9) 2214 (37.9) 1849 (37.2) 1626 (38.3) 223 (30.7)
 Obese (≥30) 1413 (24.2) 922 (18.5) 789 (18.6) 133 (18.3)
 Missing 124 (2) 122 (2.5) 46 (1.1) 76 (10.4)
Body mass index at age 20 years
(kg/m2)
 Underweight (<18.5) 423 (7.2) 439 (8.8) 373 (8.8) 66 (9.1)
 Normal (18.5-24.9) 3989 (68.2) 3595 (72.3) 3121 (73.6) 474 (65.2)
 Overweight (25.0-29.9) 969 (16.6) 638 (12.8) 549 (12.9) 89 (12.2)
 Obese (≥30) 230 (3.9) 112 (2.3) 95 (2.2) 17 (2.3)
 Missing 236 (4.1) 186 (3.8) 105 (2.5) 81 (11.2)
Cigarette smoking
 Current^^ 662 (11.3) 638 (12.8) 537 (12.7) 101 (13.9)
 Former^ 2635 (45.1) 2056 (41.4) 1788 (42.1) 268 (36.9)
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Controls, N (%)
Variables Cases, N (%)
(n = 5847)
Total controls
(n = 4970)
Population controls
(n = 4243)
Spouse controls
(n =727)
 Never 2511 (43) 2250 (45.3) 1901 (44.8) 349 (48)
 Missing 39 (0.6) 256 (0.5) 17 (0.4) 9 (1.2)
Education
 Primary school 107 (1.8) 91 (1.8) 79 (1.9) 12 (1.6)
 Secondary school 821 (14) 658 (13.2) 541 (12.7) 117 (16.1)
 High/Senior secondary school 1310 (22.4) 958 (19.3) 789 (18.6) 169 (23.3)
 Vocational education or training 583 (10) 466 (9.4) 352 (8.3) 114 (15.7)
 University without degree 1330 (22.8) 1089 (21.9) 1025 (24.2) 64 (8.8)
 University graduation or higher 1649 (28.2) 1618 (3.6) 1444 (34) 174 (23.9)
 Missing 47 (0.8) 90 (1.8) 13 (0.3) 77 (10.6)
Annual household Income
 ≤ $15,000 319 (5.5) 190 (3.8) 186 (4.4) 4 (0.5)
 $15,000-30,000 777 (13.3) 572 (11.5) 538 (12.7) 34 (4.7)
 $30,000-45,000 1031 (17.6) 925 (18.6) 864 (20.4) 61 (8.4)
 $45,000-70,000 1068 (18.3) 933 (18.8) 870 (20.5) 63 (8.6)
 ≥ $70,000 1026 (17.5) 876 (17.6) 790 (18.6) 86 (11.8)
 Refused to answer 144 (2.5) 147 (3) 140 (3.3) 7 (1)
 Missing 1482 (25.3) 1327 (26.7) 855 (20.1) 472 (64.9)
Race
 Caucasian 5206 89) 4592 (92.4) 3944 (93) 648 (89.1)
 Other 514 (8.8) 276 (5.6) 254 (6) 22 (3)
 Missing 127 (2.2) 102 (2) 45 (1) 57 (7.9)
Diabetes mellitus
 Yes 468 (8) 376 (7.6) 340 (8) 36 (5)
 No 5360 (91.7) 4581 (92.2) 3895 (91.8) 686 (94.3)
 Missing 19 (0.3) 13 (0.2) 8 (0.2) 5 (0.7)
Aspirin intake**
 ≥5years 471 (8.1) 623 (12.5) 577 (13.6) 46 (6.3)
 <5years 884 (15.1) 888 (17.9) 806 (19) 82 (11.3)
 Never 4231 (72.4) 3263 (65.7) 2705 63.8) 558 (76.8)
 Missing 261 (4.4) 196 (3.9) 155 (3.7) 41 (5.6)
Ibuprofen intake**
 ≥5years 172 (3) 182 (3.7) 155 (3.7) 27 (3.7)
 <5years 685 (11.7) 719 (14.5) 642 (15.1) 77 (10.6)
 Never 4756 (81.3) 3904 (78.5) 3332 (78.5) 572 (78.7)
 Missing 234 (4) 165 (3.3) 114 (2.7) 51 (7)
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Controls, N (%)
Variables Cases, N (%)
(n = 5847)
Total controls
(n = 4970)
Population controls
(n = 4243)
Spouse controls
(n =727)
Multivitamin intake**
 ≥5years 1553 (26.6) 1463 (29.4) 1361 (32.1) 102 (14)
 <5years 1102 18.8) 859 (17.3) 752 (17.7) 107 (14.7)
 Never 2845 (48.7) 2434 (49) 1975 (46.5) 459 (63.2)
 Missing 347 (5.9) 214 (4.3) 155 (3.7) 59 (8.1)
Regular physical activity*
 Yes 5023 (85.9) 4287 (86.3) 3668 (86.5) 619 (85.1)
 No 90 (1.5) 108 (2.2) 89 (2.1) 19 (2.6)
 Missing 734 (12.6) 575 (11.5) 486 (11.4) 89 (12.2)
Alcohol consumption (standard drink
per day) ^^^
 Mean (SD) 1.2 (2.3) 1 (2.1) 1.1 (2.1) 0.9 (1.6)
 Missing, N 1684 1225 1075 150
Red meat consumption (number of
serve per day)
 Mean (SD) 0.66 (0.63) 0.58 (0.55) 0.54 (0.53) 0.81 (0.66)
 Missing, N 187 222 149 73
Number of live birth #
 0 374 (12.6) 269 (10.2) 230 (10.5) 39 (8.9)
 1 349 (11.8) 275 (10.4) 230 (10.5) 45 (10.3)
 2 909 (30.7) 830 (31.6) 656 (29.9) 174 (39.6)
 3 605 (20.5) 538 (20.5) 440 (20.1) 98 (22.3)
 ≥4 516 (17.4) 412 (15.7) 345 (15.8) 67 (15.3)
 Missing 206 (7) 306 (11.6) 290 (13.2) 16 (3.6)
Hormonal contraceptives#
 ≥5 years 1007 (34) 939 (35.7) 719 (32.8) 220 (50.1)
 <5 years 577 (19.5) 545 (20.7) 433 (19.8) 112 (25.5)
 Never 1192 (40.3) 1023 (38.9) 935 (42.7) 88 (20.1)
 Missing 183 (6.2) 123 (4.7) 104 (4.7) 19 (4.3)
Hormone replacement therapy#
 Estrogen-only users 491 (16.6) 473 (18) 411 (18.8) 62 (14.1)
 Progesterone and estrogen users 187 (6.3) 214 (8.1) 187 (8.5) 27 (6.2)
 Never 1879 (63.5) 1467 (55.8) 1221 (55.7) 246 (56)
 Missing 402 (13.6) 476 (18.1) 372 (17) 104 (23.7)
Anatomical location
 Proximal colon 1968 (33.6) __ __ __
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Controls, N (%)
Variables Cases, N (%)
(n = 5847)
Total controls
(n = 4970)
Population controls
(n = 4243)
Spouse controls
(n =727)
 Distal colon 1811 (31) __ __ __
 Colon unspecified 81 (1.4) __ __ __
 Rectum 1987 (34) __ __ __
Tumor MMR status
 MMR-proficient tumor 3790 (64.8) __ __ __
 MMR-deficient tumor 631 (10.8) __ __ __
 Missing 1426 (24.4) __ __ __
MMR, mismatch repair; SD, standard deviation; N, number;__, not relevant
#Questions asked only for women (2959 cases and 2630 controls)
*
regular physical activity defined as any physical activity for at least 30 minutes per week for at least 3 months
**
at least twice a week for at least 1 month
^former smokers defined as participants who had smoked at least 1 cigarette per day for at least 3 months and had quit more than 2 years before age 
at colorectal cancer or age at interview.
^^
current smokers defined as participants who had smoked at least 1 cigarette per day for at least 3 months and continued within 2 years of age at 
colorectal cancer or age at interview.
^^^4-oz. glasses of wine, or 12-oz. cans or bottles of beer or hard cider, or 1-oz. servings of sake or liquor (spirits)
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Table 2
Association between cholecystectomy and the risk of colorectal cancer overall and stratified by sex, family 
history, anatomical location and tumor mismatch repair status
Cases Controls Unadjusted Adjusted**
n/N n/N OR (95% CI) P-value OR (95% CI) P-value P-difference*
Overall 521/5847 555/4970 0.76 (0.66, 0.88) .001 0.88 (0.73, 1.08) .22
Sex
Women*** 395/2959 410/2630 0.84 (0.72, 0.99) .0 4 1.00 (0.78, 1.28) .99 .54
Men 126/2888 145/2340 0.74 (0.56, 0.97) .03 0.78 (0.53, 1.13) .19
Family history 555/4970
No 399/4599 0.75 (0.65, 0.88) <.001 0.86 (0.69, 1.06) .16
Yes 122/1248 0.90 (0.71, 1.14) .39 0.98 (0.71, 1.33) .88 .64
Anatomical location 555/4970
Proximal colon 216/1968 1.02 (0.42, 1.23) .83 0.93 (0.70, 1.24) .63 .45
Distal colon 151/1811 0.70 (0.56, 0.86) .001 0.75 (0.56, 1.02) .07
Colon unspecified 3/81 0.30 (0.09, 0.95) .04 0.59 (0.13, 2.63) .49
Rectum 151/1987 0.66 (0.53, 0.82) <.001 0.97 (0.72, 1.29) .84
Tumor MMR status 555/4970
Proficient 314/3790 0.74 (0.63, 0.87) <.001 0.86 (0.68, 1.09) .20 .54
Deficient 71/631 0.99 (0.73, 1.34) .93 0.96 (0.63, 1.49) .87
OR, Odds ratio; CI, confidence interval, MMR, mismatch repair; n, number of individuals with cholecystectomy; N, total number
*for stratified analysis by sex: it was calculated using likelihood ratio tests comparing unconditional multivariable logistic regression models with 
and without an interaction term; for stratified analyses by first-degree family history, anatomical location and tumor MMR status, it was calculated 
using likelihood ratio tests on multinomial logistic regression models.
**
adjusted for sex (women or men, except for stratified analysis by sex), first-degree family history (no, yes; except for stratified analysis by family 
history), age at study recruitment (continuous), alcohol consumption (per standard drink per day), BMI (WHO categories), BMI at age 20 years 
(WHO categories), cigarette smoking (never, former, current), aspirin (non-users, <5 years use, ≥5 years use), ibuprofen (non-users, <5 years use, 
≥5 years use), diabetes status (no, yes), recruitment center (Cancer Care Ontario, Fred Hutchinson Cancer Research Center, Mayo Clinic or 
University of Melbourne), regular physical activity (no, yes), and red meat consumption (serving per day)
***
For women, further adjusted for hormonal contraceptive use (non-users, <5 years use, ≥5 years use) and number of live birth (never, 1, 2, 3, ≥4)
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